Lupin Manufacturing Solutions (LMS) offers specialized CDMO solutions across high-growth modalities, including peptides, antibody-drug conjugates (ADCs), and oncology-focused programs. Our capabilities are designed to support complex, high-potency, and phase-appropriate development and manufacturing, aligned with stringent global regulatory and quality standards. With a strong focus on containment, compliance, and supply-chain reliability, LMS enables partners to advance innovative oncology and targeted therapies with confidence. Backed by Lupin’s scientific and manufacturing legacy, we deliver scalable, future-ready solutions for next-generation therapeutics.